CO96 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Baseline Patient Characteristics: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.192
https://www.valueinhealthjournal.com/article/S1098-3015(22)00393-X/fulltext
Title : CO96 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Baseline Patient Characteristics: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00393-X&doi=10.1016/j.jval.2022.04.192
First page :
Section Title :
Open access? : No
Section Order : 10158
Categories :
Tags :
Regions :
ViH Article Tags :